Skip to main content
An official website of the United States government

Funded Early Detection and Screening Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Schroeck, Florian R

Veterans Education/Res/Assn/North/Ne
United States

Replacing Invasive Cystoscopy with Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance 5R37CA275916-02 Claire Zhu, Ph.D.
Sears, Rosalie C

Oregon Health & Science University
United States

Validation of novel imaging and molecular tests for early detection of pancreatic cancer through risk-stratified community engagement programs 5U01CA278923-03 Matthew Young, Ph.D.
Sears, Rosalie C

Oregon Health & Science University
United States

An atlas of pancreatic tumorigenesis in the context of altered DNA repair occurring in high-risk individuals 1U01CA294548-01 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Segal, Leopoldo Nicolas

New York University School Of Medicine
United States

Microbial and host biomarker development for detection and prognosis of early stage non-small cell lung cancer 5U2CCA271890-03 Guillermo Marquez, Ph.D.
Semmes, Oliver John

Old Dominion University
United States

Virginia-UCLA-Toronto Biomarker Characterization Center 5U2CCA271894-04 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Sen, Subrata

University Of Tx Md Anderson Can Ctr
United States

Circulating Biomarkers and Imaging for Early Detection of Pancreatic Cancer 2U01CA214263-06 Matthew Young, Ph.D.
Shah, Sohrab P

Sloan-Kettering Inst Can Research
United States

Exploiting markers of genomic instability in high-risk pre-invasive ovarian cancer 5R01CA281928-03 Christos Patriotis, Ph.D., M.Sc.
Shain, Alan Hunter

University Of California, San Francisco
United States

Pre-cancer atlas of skin cancer 1U01CA294536-01 Nick Hodges, Ph.D.
Shu, Xiao-Ou

Vanderbilt University Medical Center
United States

Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer 5R01CA227133-05 Matthew Young, Ph.D.
Shuck, Sarah C.

Beckman Research Institute/City Of Hope
United States

Identification of metabolic adducts associated with prostate cancer progression in African American men Supplement 3R21CA282612-01S1 Guillermo Marquez, Ph.D.
Sidransky, David

Johns Hopkins University
United States

Racial differences in Immunogenetic Tumorigenesis of Head and Neck Squamous Cell Carcinoma 5R01CA265975-03 Wendy Wang, Ph.D., M.Sc.
Sieren, Jessica C

University Of Iowa
United States

Lung cancer screening efficacy enhanced through radiomic and epigenetic biomarkers 5R01CA267820-03
Simeone, Diane M

University Of California, San Diego
United States

Biomarker Validation in Pancreatic Cystic Neoplasms 7U01CA282272-02 Matthew Young, Ph.D.
Singal, Amit

Ut Southwestern Medical Center
United States

Clinical Validation Center for Hepatocellular Carcinoma 5U01CA271887-03 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Singal, Amit

Ut Southwestern Medical Center
United States

Clinical Validation Center for Hepatocellular Carcinoma 5U01CA271887-03 Indu Kohaar, Ph.D., M.Phil., M.Sc.